| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| FRESH2 GROUP Aktie jetzt für 0€ handeln | |||||
| 17.06. | NSE - Fresh2 Group Ltd - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities | 3 | SEC Filings | ||
| 11.06. | Delisting of Securities of Blue Star Foods Corp.; Altamira Therapeutics Ltd.; Evergreen Corporation; Fresh2 Group Limited; Coliseum Acquisition Corp.; The Real Good Food Company, Inc.; Mynaric AG; byNordic Acquisition Corporation; ... | 813 | GlobeNewswire (Europe) | NEW YORK, June 11, 2025 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the common stock of Blue Star Foods Corp. Blue Star Foods Corp.'s stock was suspended on December... ► Artikel lesen | |
| 11.02. | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 11.02.2025 | 590 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 11.02.2025Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 11.02.2025ISIN NameCA53635T1084 LIQUID... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| GERRESHEIMER | 24,840 | -5,41 % | INDEX-MONITOR: JPMorgan erwartet Aumovio im MDax - Dax wohl unverändert | FRANKFURT (dpa-AFX) - Im Dax dürfte zur Index-Überprüfung an diesem Mittwoch alles beim Alten bleiben. Eine Änderung erwartet die US-Bank JPMorgan dagegen im Index der mittelgroßen Unternehmen, die... ► Artikel lesen | |
| TELADOC HEALTH | 6,512 | -0,17 % | Teladoc Health, Inc.: Teladoc Health Announces Chief Financial Officer Transition | NEW YORK, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader in virtual care, today announced that Mala Murthy will be stepping down from her role as Chief Financial... ► Artikel lesen | |
| ROKU | 87,11 | +1,33 % | NextTrip, Inc.: NextTrip's JOURNY Expands Global Reach with Launch on Apple iOS, Roku, and Android | New Apps Deepen Audience Engagement and Extend JOURNY's Rebrand Momentum Across Major Platforms SANTA FE, NEW MEXICO / ACCESS Newswire / December 4, 2025 / NextTrip, Inc. (NASDAQ:NTRP) ("NextTrip,"... ► Artikel lesen | |
| BICO GROUP | 1,735 | -4,30 % | BICO Group AB: Publication of BICO Group AB: Interim report Q3 2025 | Organic sales growth in a continued soft market
Q3 2025 SummaryLife Science Solutions showed 4 percent organic sales growth YoY, which is in line with market performance. SCIENION continued to perform... ► Artikel lesen | |
| PLUS THERAPEUTICS | 0,626 | -3,74 % | Plus Therapeutics Inc.: Plus Therapeutics Highlights Three REYOBIQ Clinical Data Presentations at 2025 WFNOS/SNO Annual Meeting | ||
| MCKESSON | 689,00 | -0,78 % | Dividendenbekanntmachungen (01.12.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ACNB CORPORATION US0008681092 0,38 USD 0,3276 EUR ADVANCED DRAINAGE SYSTEMS INC US00790R1041 0,18 USD 0,1551 EUR AGNICO EAGLE MINES... ► Artikel lesen | |
| ATOSSA THERAPEUTICS | 0,674 | -1,17 % | Atossa Therapeutics Inc: Atossa Therapeutics Details Accelerated FDA Strategy to Advance (Z)-Endoxifen Across Breast Cancer Continuum | Company positioned to pursue expedited regulatory pathways in metastatic, neoadjuvant, and risk-reduction settings
SEATTLE, Dec. 4, 2025 /PRNewswire/ -- Atossa... ► Artikel lesen | |
| UNIDOC HEALTH | 0,120 | +0,33 % | UniDoc erhält Bestellung für Health Cubes | - Die drei Einheiten sind für Demonstrationszwecke bei Verizon Innovation Labs
bestimmt
VANCOUVER, BC / 25. November 2025 / IRW-Press / UniDoc Health Corp. (CSE: UDOC) (FWB: L7T)... ► Artikel lesen | |
| NETRAMARK | 0,635 | -4,51 % | NetraMark Holdings Inc.: NetraAI-Studie zur Veröffentlichung im npj Digital Medicine, Teil des Nature-Portfolios, angenommen | TORONTO, ON, 8. Dezember 2025 / IRW-Press / NetraMark Holdings Inc. (das "Unternehmen" oder "NetraMark") (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0),
ein führendes Unternehmen im Bereich der... ► Artikel lesen | |
| SONOMA PHARMACEUTICALS | 2,480 | -100,00 % | Sonoma Pharmaceuticals, Inc.: National Rosacea Society Awards Seal of Acceptance to Sonoma Pharmaceuticals for Reliefacyn Advanced | BOULDER, CO / ACCESS Newswire / November 13, 2025 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous... ► Artikel lesen | |
| CO-DIAGNOSTICS | 0,306 | -4,97 % | Co-Diagnostics, Inc. - 8-K, Current Report | ||
| VERU | 2,615 | +5,02 % | Veru Inc.: Veru Reports Fiscal 2025 Third Quarter Financial Results and Clinical Program Progress | --Company reported positive efficacy and safety data from Phase 2b QUALITY study showing enobosarm added to semaglutide led to preservation of muscle, greater fat loss, and fewer gastrointestinal... ► Artikel lesen | |
| CYTOSORBENTS | 0,590 | -5,90 % | Cytosorbents Corp: CytoSorbents Reports Third Quarter 2025 Financial Results and Provides Business Update | Third quarter 2025 revenue of $9.5 million, up 10% year-over-year
Amended credit agreement with Avenue Capital Group which strengthens our balance sheet... ► Artikel lesen | |
| LIMES SCHLOSSKLINIKEN | 328,00 | +0,61 % | Limes Schlosskliniken: Dividende wird ein Thema | In diesem Jahr hat Limes Schlosskliniken das Portfolio um zwei Standorte erweitert: eine Spezialklinik für Jugendliche am Abtsee (Bayern) und eine Klinik in Lindlar (Bergisches Land) ergänzen die bisherigen... ► Artikel lesen | |
| VOLITIONRX | 0,295 | -1,64 % | VolitionRx Limited Announces Third Quarter 2025 Financial Results and Business Update | Conference call to discuss financial and operational results scheduled for Friday, November 14 at 8:30 a.m. U.S. Eastern Time
HENDERSON, Nevada, Nov. 13, 2025... ► Artikel lesen |